United States · Series A startup
7 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$78Mraised across 7 rounds since 2006, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $2.5M sold, first sale May 2014
Reported by finsmes.comSEC filing: $19M sold, first sale Jul 2012
Reported by pehub.comSEC filing: $19M sold, first sale Apr 2011
From the SEC filings it signed: 2 on the team.
On the board, as filediGeoff BrookeHoward ""Ted"" GreeneInna Martin EitanJames BlairJames Mervis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Domain Associates
GBS Ventures
BioPacific Investors
MPM Capital
Novartis
Square 1 BankVersant Ventures/ AstellasMissing a round, or an investor who was in one? Tell us.
CoDa Therapeutics's investors include Domain Associates, GBS Ventures, BioPacific Investors, MPM Capital and Novartis, and 2 more on record.
CoDa Therapeutics has raised $78M across 7 rounds since 2006.
CoDa Therapeutics's most recent round was a Series A of $19M in Sept 2018.
CoDa Therapeutics's largest round on record is $20M (Series B), in Jul 2012.
CoDa Therapeutics's first round on record, in Oct 2006, was backed by Domain Associates and GBS Ventures.
CoDa Therapeutics's latest named round is a Series A, in Sept 2018.
CoDa Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
